THE STEM CELL MARKER SALL4 AND CIRCULATING TUMOR CELLS AS BIOMARKERS FOR PROSTATE CANCER PROGNOSES AND THERAPEUTICS
$479,000FY2008Department of EnergyDOE
Nevada Cancer Institute, Las Vegas NV
Investigators
View source on USAspending →THE STEM CELL MARKER SALL4 AND CIRCULATING TUMOR CELLS AS BIOMARKERS FOR PROSTATE CANCER PROGNOSES AND THERAPEUTICS · GrantIndex